Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia · Delayed Price · Currency is SAR 104.90
+1.40 (1.35%)
Apr 14, 2026, 1:16 PM AST
TADAWUL:4016 Revenue
In the year 2025, Middle East Pharmaceutical Industries Company had annual revenue of 460.48M SAR with 16.87% growth. Middle East Pharmaceutical Industries Company had revenue of 137.52M in the quarter ending December 31, 2025, with 1.12% growth.
Revenue
460.48M
Revenue Growth
+16.87%
P/S Ratio
4.50
Revenue / Employee
629.94K
Employees
731
Market Cap
2.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 460.48M | 66.48M | 16.87% |
| Dec 31, 2024 | 394.00M | 55.56M | 16.42% |
| Dec 31, 2023 | 338.44M | 35.78M | 11.82% |
| Dec 31, 2022 | 302.66M | 15.44M | 5.38% |
| Dec 31, 2021 | 287.22M | -14.44M | -4.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition